Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending January 02, 2008. The report serves as a notification to the market regarding the Company's total voting rights and capital structure in conformity with Disclosure and Transparency Rule 5.6.1R.
Key Financial Metrics
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on share capital and voting rights.
- Issued Share Capital (as of Dec 31, 2007): 6,012,587,026 Ordinary shares of 25p each.
- Treasury Shares: 504,194,158 Ordinary shares.
- Total Voting Rights: 5,508,392,868.
Material Changes
The filing text does not provide data for comparison with prior periods regarding financial performance or capital structure changes.
Guidance, Outlook, and Risks
The filing text does not provide clear values or commentary regarding future guidance, outlook, risks, contingencies, or unusual items. The document is a statutory notification of share counts for shareholder compliance calculations.
Key Facts for Investor Verification
- Verify the total number of voting rights (5,508,392,868) against the issued share capital minus treasury shares.
- Confirm the date of the share capital snapshot (December 31, 2007) for accurate ownership threshold calculations.
- Note that this filing does not contain financial performance data; refer to Form 20-F for annual financial results.